BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38835706)

  • 1. Expert Practices in Hidradenitis Suppurativa Flare Management: A Cross-Sectional Survey Study.
    Masson R; Park S; Shi VY; Hsiao JL; Aleshin MA
    Skin Appendage Disord; 2024 Jun; 10(3):224-228. PubMed ID: 38835706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No-shows to hidradenitis suppurativa clinic visits: Patient perspectives.
    Fragoso NM; Masson R; Shih T; Mayo T; Okoye G; Shi VY; Hsiao JL
    Skin Health Dis; 2024 Apr; 4(2):e322. PubMed ID: 38577047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series.
    Riis PT; Boer J; Prens EP; Saunte DM; Deckers IE; Emtestam L; Sartorius K; Jemec GB
    J Am Acad Dermatol; 2016 Dec; 75(6):1151-1155. PubMed ID: 27692735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing perimenstrual flares of hidradenitis suppurativa.
    Collier EK; Price KN; Grogan TR; Naik HB; Shi VY; Hsiao JL
    Int J Womens Dermatol; 2020 Dec; 6(5):372-376. PubMed ID: 33898701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study.
    Masson R; Shih T; Park S; De DR; Gierbolini A; Alavi A; Garg A; Micheletti RG; Shi VY; Hsiao JL
    Dermatology; 2023; 239(5):732-737. PubMed ID: 37385230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: A prospective study.
    Iannone M; Janowska A; Oranges T; Balderi L; Benincasa BB; Vitali S; Tonini G; Morganti R; Romanelli M; Dini V
    Dermatol Ther; 2021 Sep; 34(5):e15068. PubMed ID: 34297465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A narrative review of the definition of 'flare' in hidradenitis suppurativa.
    Kirby JS; Moore B; Leiphart P; Shumaker K; Mammis-Gierbolini A; Benhadou F; Del Marmol V
    Br J Dermatol; 2020 Jan; 182(1):24-28. PubMed ID: 31025310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of Emergency Medicine Physicians on Hidradenitis Suppurativa Care.
    Atluri S; De DR; Shih T; Dagenet CB; Masson R; Tran KA; Ng V; Hsiao JL; Shi VY
    Skin Appendage Disord; 2024 Apr; 10(2):133-136. PubMed ID: 38572194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perspectives of wound care management in hidradenitis suppurativa.
    Poondru S; Scott K; Riley JM
    Arch Dermatol Res; 2023 Aug; 315(6):1847-1850. PubMed ID: 36811730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Patient Satisfaction Associated With Intramuscular Triamcinolone Therapy for Acute Flares of Hidradenitis Suppurativa.
    Benesh G; Andriano TM; Hosgood HD; Cohen SR
    J Cutan Med Surg; 2023; 27(4):350-357. PubMed ID: 37461296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic Nicotine Dispensing Systems Compared to Traditional Cigarettes in Hidradenitis Suppurativa: A Cross-Sectional Survey of Patient and Dermatologist Perceptions.
    Poondru S; Scott K; Riley JM
    Skin Appendage Disord; 2023 Oct; 9(5):355-360. PubMed ID: 37900770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic use in hidradenitis suppurativa: patient perspectives and barriers.
    De DR; Shih T; Fixsen D; Brooks B; Hsiao JL; Shi VY
    J Dermatolog Treat; 2022 Nov; 33(7):3060-3062. PubMed ID: 35737883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.
    Rick JW; De DR; Shih T; Alavi A; Kirby JS; Naik HB; Frew JW; Sayed CJ; Hsiao JL; Shi VY
    Skin Appendage Disord; 2022 Jul; 8(4):287-290. PubMed ID: 35979524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.
    Caposiena Caro RD; Cannizzaro MV; Tartaglia C; Bianchi L
    Clin Exp Dermatol; 2020 Jun; 45(4):438-444. PubMed ID: 31630436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors related to the onset and recurrence of flares in hidradenitis suppurativa patients treated with adalimumab.
    Caposiena Caro RD; Chiricozzi A; Sechi A; Molinelli E; Venturini M; Candi E; DE Simone C; Peris K; Patrizi A; Offidani A; Calzavara-Pinton P; Bianchi L
    Ital J Dermatol Venerol; 2022 Apr; 157(2):137-141. PubMed ID: 33982548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional Triamcinolone May Not Be Beneficial for Treating Acute Hidradenitis Suppurativa Lesions: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Fajgenbaum K; Crouse L; Dong L; Zeng D; Sayed C
    Dermatol Surg; 2020 May; 46(5):685-689. PubMed ID: 31490300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
    Midgette B; Strunk A; Akilov O; Alavi A; Ardon C; Bechara FG; Cohen AD; Cohen S; Daveluy S; Del Marmol V; Delage M; Esmann S; Fisher S; Giamarellos-Bourboulis EJ; Glowaczewska A; Goldfarb N; Brant EG; Grimstad Ø; Guilbault S; Hamzavi I; Hughes R; Ingram JR; Jemec GBE; Ju Q; Kappe N; Kirby B; Kirby JS; Lowes MA; Matusiak L; Micha S; Micheletti R; Miller AP; Moseng D; Naik H; Nassif A; Nikolakis G; Paek SY; Pascual JC; Prens E; Resnik B; Riad H; Sayed C; Smith SD; Soliman Y; Szepietowski JC; Tan J; Thorlacius L; Tzellos T; van der Zee HH; Villumsen B; Wang L; Zouboulis C; Garg A
    Br J Dermatol; 2022 Dec; 187(6):927-935. PubMed ID: 36056741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased ambient outdoor temperatures are associated with increased disease flaring in hidradenitis suppurativa.
    Singh R; Fathy R; Kassamali B; Noe MH; Barbieri JS; LaChance A; Charrow AP
    Arch Dermatol Res; 2023 Dec; 316(1):49. PubMed ID: 38108861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.